封面
市场调查报告书
商品编码
1485278

疤痕治疗市场- 副产品(外用[乳膏、凝胶]、雷射[CO2、脉衝染色]、注射)、类型(萎缩性、挛缩性、肥厚性和瘢瘤、妊娠纹)、最终用途(医院、诊所、零售)药局) - 全球预测 2024 - 2032

Scar Treatment Market - By Product (Topical [Cream, Gel], Laser [CO2, Pulse-dyed], Injectables), Type (Atrophic, Contracture, Hypertrophic & Keloid Scars, Stretch Marks), End-use (Hospitals, Clinics, Retail Pharmacies) - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 178 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于烧伤、手术和创伤病例发生率上升,预计 2024 年至 2032 年疤痕治疗市场规模将以超过 9.6% 的复合年增长率扩大。雷射疗法和硅胶片等技术的巨大进步提供了更有效和微创的治疗选择,从而加速了疤痕治疗解决方案的吸引力。

由于人们越来越重视美观和对完美肌肤的渴望,消费者对疤痕治疗产品和手术的可用性的认识不断提高,推动了对多种治疗技术的偏好。优惠报销政策的推出和医疗基础设施的发展也推动了疤痕治疗疗法的采用

化妆品领域的巨额研发投资进一步促进了新配方的开发,促进了市场成长。例如,2023 年 8 月,护肤品牌 Topicals 推出了 Sealed Active Scar Primer。该产品在化妆前填充痤疮疤痕,并逐渐增强肤质。

疤痕治疗产业分为产品、类型、最终用途和地区。

从产品来看,预计2024年至2032年雷射产品领域的市场规模将达到9.6%的复合年增长率。的治疗。点阵雷射系统等雷射技术的发展正在提高治疗效果并最大限度地减少停机时间。消费者对非侵入性和痛苦最小的疤痕治疗方案的日益偏好也将刺激对雷射产品的需求。

根据类型,妊娠纹领域的疤痕治疗市场预计从 2024 年到 2032 年将以 9.2% 的成长率扩张。除了人们对妊娠纹治疗的认识和接受度不断提高之外,专为妊娠纹设计的外用乳膏、油和雷射疗法的可用性不断增加,也加速了产品的渗透。

从地区来看,由于消费者对疤痕治疗选择的认识不断提高以及美容手术越来越受欢迎,欧洲疤痕治疗行业规模预计在 2024 年至 2032 年间将以 9.7% 的复合年增长率增长。该地区外科手术和创伤病例的盛行率增加。雷射疗法和硅胶片等疤痕治疗技术和产品的重大发展正在提供更有效的解决方案。有利的报销政策和医疗基础设施的存在也推动了区域市场的发展。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 皮肤病和创伤的发生率增加
      • 对美学外观的意识和关注不断提高
      • 疤痕治疗技术的进步
      • 越来越多采用微创手术
    • 产业陷阱与挑战
      • 治疗费用高
      • 不良反应的风险
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 外用产品
    • 乳霜
    • 凝胶
    • 硅胶片
    • 其他局部产品
  • 雷射产品
    • 二氧化碳雷射
    • 脉衝染色雷射
    • 其他雷射产品
  • 注射剂
  • 其他产品

第 6 章:市场估计与预测:按类型,2018 - 2032

  • 主要趋势
  • 萎缩性疤痕
  • 肥厚性疤痕和疤痕疙瘩
  • 挛缩疤痕
  • 妊娠纹

第 7 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 诊所
  • 零售药局
  • 医疗水疗
  • 其他最终用户

第 8 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • CCA Industries, Inc.
  • Clayton, Dubilier & Rice, LLC
  • Lumenis Be Ltd.
  • McKesson Corporation
  • Merz Pharma GmbH & Co. KGaA
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • SMITH & NEPHEW plc
  • Sonoma Pharmaceuticals, Inc.
  • Suneva Medical
简介目录
Product Code: 8467

Scar Treatment Market size is projected to expand at over 9.6% CAGR from 2024 to 2032, led by the rising incidence of burns, surgeries, and trauma cases. Strong advancements in technology, like laser therapy and silicone gel sheets are offering more effective and minimally invasive treatment options, subsequently accelerating the appeal of scar treatment solutions.

The increasing awareness about the availability of scar treatment products and procedures among consumers is pushing the preference for several treatment techniques due to the growing emphasis on aesthetics and the desire for flawless skin. The rollout of favorable reimbursement policies and healthcare infrastructure developments is also driving the adoption of scar treatment therapies

The hefty R&D investments in cosmetic sector are further promoting the development of new formulations, adding to the market growth. For instance, in August 2023, Topicals, a skincare brand, introduced its Sealed Active Scar Primer. This product fills acne scars before makeup application and enhances skin texture gradually.

The scar treatment industry is bifurcated into product, type, end-use, and region.

In terms of product, the market size from the laser products segment is estimated to record 9.6% CAGR from 2024 to 2032. Laser therapy offers precise and targeted treatment for various types of scars, including acne scars and surgical scars. The evolution in laser technology, such as fractional laser systems is enhancing treatment efficacy and minimizing downtime. The increasing consumer preference for non-invasive and minimally painful scar treatment options will also fuel the demand for laser products.

Based on type, the scar treatment market from the stretch marks segment is anticipated to expand at 9.2% growth rate from 2024 to 2032. This is owing to rising episodes of pregnancy, rapid weight gain or loss, and puberty. The increasing availability of topical creams, oils, and laser therapies specifically designed for stretch marks is accelerating the product penetration in addition to the growing awareness and acceptance of stretch mark treatments.

Regionally, the Europe scar treatment industry size is predicted to grow at 9.7% CAGR between 2024 and 2032, led by the increasing awareness about scar treatment options and rising popularity of aesthetic procedures among consumers. The prevalence of surgical procedures and trauma cases has grown across the region. Significant developments in scar treatment technologies and products, like laser therapy and silicone gel sheets are offering more effective solutions. The presence of favorable reimbursement policies and healthcare infrastructure are also driving the regional market progression.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of skin disorders and trauma
      • 3.2.1.2 Rising awareness and concern for aesthetic appearance
      • 3.2.1.3 Advancements in scar treatment technologies
      • 3.2.1.4 Increasing adoption of minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of treatment
      • 3.2.2.2 Risk of adverse effects
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Topical products
    • 5.2.1 Creams
    • 5.2.2 Gels
    • 5.2.3 Silicon sheets
    • 5.2.4 Other topical products
  • 5.3 Laser products
    • 5.3.1 CO2 laser
    • 5.3.2 Pulse-dyed laser
    • 5.3.3 Other laser products
  • 5.4 Injectables
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Atrophic scars
  • 6.3 Hypertrophic and keloid scars
  • 6.4 Contracture scars
  • 6.5 Stretch marks

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Retail pharmacies
  • 7.5 Medical spa
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Mexico
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 CCA Industries, Inc.
  • 9.2 Clayton, Dubilier & Rice, LLC
  • 9.3 Lumenis Be Ltd.
  • 9.4 McKesson Corporation
  • 9.5 Merz Pharma GmbH & Co. KGaA
  • 9.6 Newmedical Technology Inc.
  • 9.7 Perrigo Company plc
  • 9.8 SMITH & NEPHEW plc
  • 9.9 Sonoma Pharmaceuticals, Inc.
  • 9.10 Suneva Medical